Balance Sheet Data

AbbVie Inc. (ABBV)

$178.81

+0.72 (+0.40%)

Year
A/P
2019
Actual
2020
Actual
2021
Actual
2022
Actual
2023
Actual
2024
Projected
2025
Projected
2026
Projected
2027
Projected
2028
Projected
Total Cash 39,9248,4799,8309,22912,81624,279.2327,754.1631,726.4336,267.2241,457.91
Total Cash (%)
Account Receivables 5,4288,8229,97711,25411,15511,580.5413,237.9815,132.6517,298.4819,774.30
Account Receivables (%)
Inventories 1,8133,3103,1283,5794,0993,968.174,536.105,185.335,927.476,775.83
Inventories (%)
Accounts Payable 1,4522,2762,8822,9343,6883,266.763,734.314,268.784,879.755,578.15
Accounts Payable (%)
Capital Expenditure -552-798-787-695-777-922.64-1,054.69-1,205.64-1,378.20-1,575.45
Capital Expenditure (%)



To support growth, companies need to keep investing in capital items – including property, plants and equipment.
To calculate this net investment,we take capital expenditure (found in the company’s statement of cash flows) and subtract non-cash depreciation (found on the income statement).
Working capital refers to the cash a company needs for day-to-day operations.
The faster a company expands, the more cash it will need.
To calculate working capital, we take current assets and subtract current liabilities.
You can find both of these on a company’s balance sheet, which is published in its quarterly and annual financial statements.